Tag: #Global Trends

Key Development At the BIO International Convention 2026 in San Diego, leading contract development and manufacturing organization (CDMO) SK pharmteco... Read more

Key Development Swiss healthcare conglomerate Novartis has formalized a high-stakes strategic partnership valued at up to $1.9 billion with U.S.-based... Read more

Key Development U.S. pharmaceutical powerhouse Eli Lilly is finalizing its regulatory and commercial strategy to launch Orforglipron—its novel, once-daily oral... Read more

Key Development Dutch technology investment conglomerate Prosus has finalized a $460 million investment round into the French healthtech trailblazer Alan,... Read more

Key Development California-based biotechnology innovator ALZpath has formalized a comprehensive global licensing agreement with Abbott Laboratories to advance blood-based diagnostic... Read more

Key Development A U.S. Federal Judge has officially dismissed global biopharmaceutical giant Pfizer from a sweeping multi-state antitrust lawsuit accusing... Read more

Key Development Global biopharmaceutical leader Eli Lilly has entered into a new strategic research collaboration with Abbisko Therapeutics to drive... Read more

Biopharmaceutical pioneer Gilead Sciences, Inc. announced that the European Commission (EC) has formally granted marketing authorization for its flagship oncology... Read more

Global science and technology leader Merck has finalized a strategic research-stage collaboration with premier venture capital firm Versant Ventures to... Read more